Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.

van Roon EN, van de Laar MA, Janssen M, Kruijsen MW, Jansen TL, Brouwers JR.

J Rheumatol. 2005 Jun;32(6):1026-30.

PMID:
15940762
2.

Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.

Hoekstra M, van de Laar MA, Bernelot Moens HJ, Kruijsen MW, Haagsma CJ.

J Rheumatol. 2003 Nov;30(11):2325-9.

PMID:
14677172
3.

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.

Hoekstra M, van Ede AE, Haagsma CJ, van de Laar MA, Huizinga TW, Kruijsen MW, Laan RF.

Ann Rheum Dis. 2003 May;62(5):423-6.

4.

[Spondylodiscitis in Bechterew's disease; inflammation or trauma? Description of 6 patients].

Lanting PJ, Rasker JJ, Kruijsen MW, Prevo RL.

Ned Tijdschr Geneeskd. 1994 Oct 1;138(40):1997-2001. Dutch.

PMID:
7935956
5.

Fatal cholestatic hepatitis caused by D-penicillamine.

Jacobs JW, Van der Weide FR, Kruijsen MW.

Br J Rheumatol. 1994 Aug;33(8):770-3. Review.

PMID:
8055207
6.

Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide.

Lanting PJ, Kruijsen MW, Rasher JJ, van den Hoogen FH, Boerbooms AM, van de Putte LB.

J Rheumatol. 1993 Dec;20(12):2175. No abstract available.

PMID:
8014959
7.

Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial.

Jeurissen ME, Boerbooms AM, van de Putte LB, Doesburg WH, Mulder J, Rasker JJ, Kruijsen MW, Haverman JF, van Beusekom HJ, Muller WH, et al.

Arthritis Rheum. 1991 Aug;34(8):961-72.

PMID:
1859490
8.

Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.

Jeurissen ME, Boerbooms AM, van de Putte LB, Kruijsen MW.

Ann Rheum Dis. 1990 Jan;49(1):25-7.

9.

Sternocostoclavicular hyperostosis or pustulotic arthroosteitis.

Prevo RL, Rasker JJ, Kruijsen MW.

J Rheumatol. 1989 Dec;16(12):1602-5.

PMID:
2625694
10.
11.

Chondrocyte impairment: another mechanism of cartilage destruction in chronic arthritis.

Kruijsen MW, van de Putte LB, van den Berg WB.

Agents Actions Suppl. 1984;14:143-51. Review. No abstract available.

PMID:
6382971
13.

Exacerbation of antigen-induced arthritis after challenge with intravenous antigen.

van de Putte LB, Lens JW, van den Berg WB, Kruijsen MW.

Immunology. 1983 May;49(1):161-7.

14.

Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience.

Speerstra F, Boerbooms AM, van de Putte LB, van Beusekom HJ, Kruijsen MW, Vandenbroucke JP.

Ann Rheum Dis. 1982;41 Suppl 1:37-9.

15.

Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake.

Kruijsen MW, van den Berg WB, van de Putte LB, van den Broek WJ.

Agents Actions. 1981 Dec;11(6-7):640-2.

PMID:
6280467
16.

Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death.

van den Berg WB, Kruijsen MW, van de Putte LB, van Beusekom HJ, van der Sluis-van der Pol M, Zwarts WA.

Br J Exp Pathol. 1981 Jun;62(3):308-16.

17.

Influence of antigen-induced arthritis on connective tissue call metabolism.

van den Berg WB, Kruijsen MW, van de Putte LB.

Agents Actions. 1980 Dec;10(6):493-5.

PMID:
7270334
18.

Pathological fracture of the odontoid process in rheumatoid arthritis.

Storms GE, Kruijsen MW, Van Beusekom HJ, Van de Putte LB, Boerbooms AM, Penn WH, Van Rens TJ.

Neth J Med. 1980;23(2):120-22. No abstract available.

PMID:
7374865

Supplemental Content

Loading ...
Support Center